SMS Lifesciences India Ltd.

View in App
665.25 -4.90 ▼-0.7%

03 May 2024, 04:01:00 PM
Volume: 492

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.smslife.in
Market Cap 202.62 Cr.
Enterprise Value(EV) 305.48 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 16.17 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 41.45 Trailing Twelve Months Ending 2023-12
Industry PE 42.15 Trailing Twelve Months Ending 2023-12
Book Value / Share 566.22 Trailing Twelve Months Ending 2023-12
Price to Book Value 1.18 Calculated using Price: 670.20
Dividend Yield 0.22 Period Ending 2023-03
No. of Shares Subscribed 0.30 Cr. 3,023,287 Shares
FaceValue 10
About SMS Lifesciences India Ltd.
SMS Lifesciences India is presently engaged in the business of manufacturing, buying, selling, offering consultancy, importing and exporting, acting as commission agents and generally dealing with of all types of Organic & Inorganic Chemicals, Pharmaceuticals, API and Intermediates.

SMS Lifesciences India Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

SMS Lifesciences India Ltd. Performance

View details >>
1 Day
-0.73%
1 Week
-1.92%
1 Month
-0.02%
3 Month
+15.66%
6 Month
+34.80%
1 Year
+19.86%
2 Year
-1.15%
5 Year
+23.88%
10 Year

SMS Lifesciences India Ltd. Fundamental Ratios

View details >>
5 years 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 16.78 9.17 11.07 17.98 7.09
Return on Capital Employed (%) 20.14 11.91 12.96 18.42 9.44
Return on Assets (%) 6.45 3.83 4.82 7.54 2.98

SMS Lifesciences India Ltd. Balance Sheet

View details >>
Particulars 6 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 106 116 129 152 169 167
Non Curr. Liab. 39 50 59 56 73 64
Curr. Liab. 132 90 119 143 137 135
Minority Int. 13 20 16
Equity & Liab. 276 256 307 364 398 383
Non Curr. Assets 128 146 176 201 236 236
Curr. Assets 149 110 131 164 163 147
Misc. Exp. not W/O
Total Assets 276 256 307 364 398 383

SMS Lifesciences India Ltd. Profit and Loss

View details >>
Particulars 6 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 378 261 266 350 316 280
Other Income 3 2 2 2 3 4
Total Income 380 263 267 352 319 284
Total Expenditure -343 -235 -235 -316 -287 -258
PBIDT 37 28 32 36 32 26
Interest -6 -5 -5 -6 -7 -9
Depreciation -6 -8 -8 -10 -11 -14
Taxation -8 -4 -6 -7 -5 -3
Exceptional Items 13 2 2
PAT 18 10 14 25 11 2
Minority Interest 0 0 3
Share Associate
Other Related Items
Consolidated Net Profit 18 10 14 25 11 5
Adjusted EPS 59 34 45 84 38 16

SMS Lifesciences India Ltd. Cash Flow

View details >>
Particulars 5 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 30 15 35 -11 15
Cash Fr. Inv. -44 -27 -26 -7 -31
Cash Fr. Finan. 15 12 -3 11 17
Net Change 1 0 6 -8 0
Cash & Cash Eqvt 2 2 9 1 1

SMS Lifesciences India Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 68.96 69.85 69.86 70.32 70.32 70.32 70.32 70.68 71.19
Public 31.04 30.15 30.14 29.68 29.68 29.68 29.68 29.32 28.81
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 3.48 3.43 3.43 3.41 3.41 3.41 3.41 0.00 0.00
No. of Shareholders (in Lacs)

SMS Lifesciences India Ltd. Announcements

View details >>
Thu, 25 Apr 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Suresh Babu Potluri
Mon, 22 Apr 2024
Compliance Certificate (PCS)
Disclosure pursuant to Regulation 40 of SEBI (Listing Obligations & Disclosure Requirments) Regulations 2015.
Thu, 11 Apr 2024
Compliance Certificate (RTA)
Disclosure pursuant to Reg. 7(3) of SEBI (Listing Obligations and Disclosure Requirement) Regulations 2015.

SMS Lifesciences India Ltd. Technical Scans

View details >>
Fri, 03 May 2024
High Delivery Percentage High Delivery Percentage
Close Within 52 Week High Zone Close Within 52 Week High Zone
Making Lower Lows for 2 Days Making Lower Lows for 2 Days
High Increase in 3 Months High Increase in 3 Months
High Increase in 6 Months High Increase in 6 Months

SMS Lifesciences India Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 361,915.69 1,508.40 -0.7%
Cipla Ltd. 115,033.60 1,424.40 +0.3%
Dr. Reddy's Laboratories Ltd. 105,928.76 6,332.85 +0.7%
Divi's Laboratories Ltd. 104,873.36 3,937.05 -0.7%
Zydus Lifesciences Ltd. 100,321.53 992.00 +0.4%
Mankind Pharma Ltd. 92,708.18 2,305.15 -1.2%
Torrent Pharmaceuticals Ltd. 92,483.60 2,732.60 +2.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 40.64 1,508.40 -0.7%
Cipla Ltd. Consolidated 2023-12 31.02 1,424.40 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.26 6,332.85 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-12 75.83 3,937.05 -0.7%
Zydus Lifesciences Ltd. Consolidated 2023-12 33.74 992.00 +0.4%
Mankind Pharma Ltd. Consolidated 2023-12 53.68 2,305.15 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 61.90 2,732.60 +2.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.80 1,508.40 -0.7%
Cipla Ltd. Consolidated 2023-12 4.44 1,424.40 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.94 6,332.85 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-12 8.05 3,937.05 -0.7%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.32 992.00 +0.4%
Mankind Pharma Ltd. Consolidated 2023-12 10.44 2,305.15 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.93 2,732.60 +2.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,508.40 -0.7%
Cipla Ltd. Consolidated 2023-03 0.02 1,424.40 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,332.85 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,937.05 -0.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 992.00 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,305.15 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,732.60 +2.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,508.40 -0.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,424.40 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,332.85 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,937.05 -0.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 992.00 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,305.15 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,732.60 +2.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,508.40 -0.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,424.40 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,332.85 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,937.05 -0.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 992.00 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,305.15 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,732.60 +2.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,508.40 -0.7%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,424.40 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,332.85 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,937.05 -0.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 992.00 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,305.15 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,732.60 +2.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,508.40 -0.7%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,424.40 +0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,332.85 +0.7%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,937.05 -0.7%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 992.00 +0.4%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,305.15 -1.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,732.60 +2.2%

SMS Lifesciences India Ltd. FAQ's

What is SMS Lifesciences share price?
Can I buy SMS Lifesciences shares now?
What is the Dividend Yield of SMS Lifesciences?
What is the Market Cap of SMS Lifesciences?
What are the key metrics to analyse SMS Lifesciences?
What is the 52 Week High and Low of SMS Lifesciences?
What is the trend of SMS Lifesciences share price?